They received positive results through animal testing this year and were approved to start human trials back in April. Dr. Kayvon Modjarrad, director of the Walter Reed Infectious Disease department, confirmed to Defense One that Phase I of trials against the Omicron and other variants were completed earlier this month.
Modjarrad said that the reason such a vaccine needed to be studied was due to the “accelerating emergences of human coronaviruses throughout the past two decades,” and the multiple variants of SARS-CoV-2 (the virus that causes a Covid-19 infection) we’ve seen within the past two years alone.
“It’s very exciting to get to this point for our entire time and I think for the entire Army as well,” he added.
“With Omicron, there’s no way really to escape this virus. You’re not going to be able to avoid it. So I think pretty soon either the whole world will be vaccinated or have been infected,” Modjarrad said.
For more information on Covid-19, the pandemic, and vaccines, please click here.
Get the latest news 24/7 on The Black Information Network. Listen now on the iHeartRadio appor click HERE to tune in live